Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023;26(7):768-776.
doi: 10.22038/IJBMS.2023.68331.14913.

Anticancer activity of Pseudomonas aeruginosa derived peptide with iRGD in colon cancer therapy

Affiliations

Anticancer activity of Pseudomonas aeruginosa derived peptide with iRGD in colon cancer therapy

Atieh Yaghoubi et al. Iran J Basic Med Sci. 2023.

Erratum in

Abstract

Objectives: Colon cancer is well-known as a life-threatening disease. Since the current treatment modalities for this type of cancer are powerful yet face some limitations, finding novel treatments is required to achieve better outcomes with fewer side effects. Here we investigated the therapeutic potential of Azurin-p28 alone or along with iRGD (Ac-CRGDKGPDC-amide) as a tumor-penetrating peptide and 5-fluorouracil (5-FU) for colon cancer.

Materials and methods: Inhibitory effect of p28 with or without iRGD/5-FU was studied in CT26 and HT29, as well as the xenograft animal model of cancer. The effect of p28 alone or along with iRGD/5-FU on cell migration, apoptotic activity, and cell cycle of the cell lines was assessed. Level of the BAX and BCL2 genes, tumor suppressor genes [(p53 and collagen type-Iα1 (COL1A1), collagen type-Iα2 (COL1A2)] were assessed by quantitative RT-PCR.

Results: These findings show that using p28 with or without iRGD and 5-FU raised the level of p53 and BAX but decreased BCL2, compared with control and 5-FU groups in tissues of the tumor, which result in raising the apoptosis.

Conclusion: It seems that p28 may be used as a new therapeutic approach in colon cancer therapy that can enhance the anti-tumor effect of 5-FU.

Keywords: Azurin-p28; Bacterial peptide; Colon cancer; Irgd; Pseudomonas aeruginosa.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that have no conflicts of interest

Figures

Figure 1
Figure 1
A: Schematic representation of the experimental methodology and mouse colon model; B: Workflow
Figure 2
Figure 2
IC50 values for the peptide-treated L929, CT26, and HT29 cells
Figure 3
Figure 3
Ability of peptides to cause apoptosis in cancer cell lines
Figure 4
Figure 4
Shows how colon cancer cell lines’ cell cycles are affected by p28
Figure 5
Figure 5
Shows how p28 prevents colon cancer cells from migrating and encroaching
Figure 6
Figure 6
shows how p28, either alone or in combination with iRGD and 5-FU, inhibits the development of CT26 cells in xenograft nude mice
Figure 7
Figure 7
Shows microscopic findings from the xenograft mouse model showing necrosis and its impact on organs
Figure 8
Figure 8
Trichrome staining shows the presence of fibrotic tissue and an increase of collagen in tumor tissue
Figure 9
Figure 9
Shows the impact of p28 on indicators of oxidative, cytokines of inflammation, as well as genes that promote fibrosis

Similar articles

Cited by

References

    1. Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. Cancer J Clin. 2023;73:17–48. - PubMed
    1. Cao C, Yan TD, Black D, Morris DL. A systematic review and meta-analysis of cytoreductive surgery with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis of colorectal origin. Ann Surg Oncol. 2009;16:2152–2165. - PubMed
    1. Koppe MJ, Boerman OC, Oyen WJ, Bleichrodt RP. Peritoneal carcinomatosis of colorectal origin: Incidence and current treatment strategies. Ann Surg. 2006;243:212–222. - PMC - PubMed
    1. Portilla AG, Cendoya I, De Tejada IL, Olabarria I, de Lecea CM, Magrach L, et al. Peritoneal carcinomatosis of colorectal origin Current treatment. Review and update. Rev Esp Enferm Dig. 2005;97:716–737. - PubMed
    1. Lemoine L, Sugarbaker P, Van der Speeten K. Pathophysiology of colorectal peritoneal carcinomatosis: Role of the peritoneum. World J Gastroenterol. 2016;22:7692–7707. - PMC - PubMed

LinkOut - more resources